Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: pediatric rheumatology

Non-Invasive Vagus Nerve Stimulation Tolerated, Effective for Rheumatoid Arthritis

Lisa Rapaport  |  March 24, 2021

(Reuters Health)—Non-invasive vagus nerve stimulation is safe and effective as an intervention for rheumatoid arthritis (RA), a small proof-of-concept study suggests. The study enrolled 35 patients with active RA and an inadequate response to therapy with disease-modifying anti-rheumatic drugs (DMARDs). All DMARDS were discontinued four weeks prior to the trial. For the study, all participants…

Filed under:ConditionsRheumatoid Arthritis Tagged with:Rheumatoid Arthritis (RA)vagus nerve stimulation

Autoantibodies Against LINE-1 p40 May Be More Common in Patients with Active SLE

Vanessa Caceres  |  March 17, 2021

Researchers found nearly all systemic lupus erythematosus (SLE) patients have autoantibodies against long interspersed nuclear elements (LINE-1) p40. These findings suggest LINE-1 may be involved in the pathogenesis of SLE.

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:autoantibodiesSLE

Rheum After 5: Dr. Mehta, a Rheumatologist & Wheel of Fortune Winner

Carol Patton  |  March 15, 2021

Updated 12/20/2022 to add a video link to the episode. Fire truck. Those are among the favorite words of Jay Mehta, MD, a pediatric rheumatologist and rheumatology fellowship director at Children’s Hospital of Philadelphia.  When he was in high school, Jay appeared on the TV game show, Wheel of Fortune, during My Favorite Teacher week….

Filed under:ProfilesRheum After 5 Tagged with:Dr. Jay Mehta

Prostock-studio / shutterstock.com

Case Report: Evans Syndrome in Lupus

Matthew J. Herrmann, MD, & Faizah Siddique, MD  |  March 15, 2021

Rheumatologists are in the unique position of diagnosing and treating rare auto-inflammatory and autoimmune diseases. Although systemic lupus erythematosus (SLE) often has textbook presentations, it is a heterogeneous condition with a wide variety of disease manifestations.  In 2019, the European League Against Rheumatism and the ACR introduced new classification criteria to help diagnose this condition.1…

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:case reportEvans Syndrome

CDC-Funded RISE Project Aims to Improve Systemic Lupus Erythematosus Patient Outcomes

Allison Plitman  |  February 19, 2021

In September 2020, the ACR received a $7 million grant for a four-pronged SLE approach that seeks to address gaps and inequities in SLE through physician education, medical school outreach, pediatric support and disease management.

Filed under:American College of RheumatologyEMRsSystemic Lupus Erythematosus Tagged with:RISE registrysystemic lupus erythematosus (SLE)

Updated Clinical Practice Guidelines for Lyme Disease, Lyme Arthritis

Elizabeth Hofheinz, MPH, MEd  |  February 16, 2021

A team of healthcare practitioners and researchers, spearheaded by the Infectious Diseases Society of America (IDSA), the American Academy of Neurology (AAN) and the ACR, has developed updated evidence-based clinical practice guidelines for the prevention, diagnosis and treatment of Lyme disease. The 2020 guidelines cover a wide variety of Lyme disease manifestations, including Lyme arthritis. Linda…

Filed under:Conditions Tagged with:GuidelinesLyme arthritisLyme Disease

ACR Convergence 2020

Interfering with Interferon: Experts Discuss IFN Signaling & IFN Inhibition Treatment Possibilities

Mary Beth Nierengarten  |  January 25, 2021

NIH investigators describe key features and genetic causes of Mendelian interferonopathies, & treatment approaches that may indicate the efficacy of IFN inhibition.

Filed under:ACR ConvergenceConditionsMeeting Reports Tagged with:ACR Convergence 2020interferonJAK inhibitorsjakinibsignaling

Advancing the ACR’s Legislative Priorities in 2021

Zach Wallace, MD, MSc  |  January 11, 2021

With a new Congress and many new legislators in key leadership positions, your support today will help RheumPAC start the year off strong.

Filed under:Legislation & Advocacy Tagged with:legislation and advocacyRheumPACZachary Wallace

Evaluation & Treatment of Systemic Sclerosis-ILD in the New Decade

Thomas R. Collins  |  December 17, 2020

ACR Convergence panelists discussed how to monitor SSc-ILD patients for ILD severity & the brightening prospects for therapy.

Filed under:ACR ConvergenceConditionsMeeting Reports Tagged with:ACR Convergence 2020ILDinterstitial lung disease (ILD)Systemic sclerosis

COVID-19 Perspectives Shared in ACR Convergence Opening Session

Thomas R. Collins  |  November 23, 2020

ACR CONVERGENCE 2020—Eric Rubin, MD, PhD, took over as editor in chief of the New England Journal of Medicine in September 2019, just a few months before COVID-19 began taking over the world. Since then, Dr. Rubin’s perspective on the pandemic has been unlike that of any other person: He has led reviews of a…

Filed under:ACR ConvergenceMeeting Reports Tagged with:ACR Convergence 2020COVID-19Ellen GravalleseEric Rubin

  • « Previous Page
  • 1
  • …
  • 64
  • 65
  • 66
  • 67
  • 68
  • …
  • 95
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences